Use of EtCO2 as a PaCO2 Predictor Under Non Invasive Ventilation (NIV) in Cases of Acute Hypercapnic Respiratory Failure

University of Lausanne Hospitals11 enrolled

Overview

In patients treated by Non invasive ventilation (NIV) due to acute hypercapnic respiratory failure, the interest of using the End-tidal Co2 measurement device "Capnostream" to evaluate PaCo2 and PaCo2 variations over time will be evaluated. Measurements will be done under normal expiration and under prolonged active and passive expiration maneuvers.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hypercapnic Respiratory Failure

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * ICU patient equipped with arterial line * NIV requirement * Hypercapnia: PaCO2 \> 45mmhg Exclusion Criteria: * Severe hemodynamic instability * Severe psychiatric disorders * nasal lesions * denied consent

Locations (1)

Intensive care and burn unit, University Hospital of Lausanne

Lausanne, Switzerland

Outcomes

Primary Outcomes

Comparison between EtCO2,PaCO2 and PaCO2 variation under NIV during both spontaneous expiration and prolonged expiration

Time frame: Sixty minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.